Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fibromyalgia Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Serotonin Norepinephrine Reuptake Inhibitors
1.2.3 GABA Analogs
1.2.4 Other
1.3 Market by Application
1.3.1 Global Fibromyalgia Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Fibromyalgia Drugs Market Perspective (2018-2033)
2.2 Fibromyalgia Drugs Growth Trends by Region
2.2.1 Global Fibromyalgia Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Fibromyalgia Drugs Historic Market Size by Region (2018-2023)
2.2.3 Fibromyalgia Drugs Forecasted Market Size by Region (2024-2033)
2.3 Fibromyalgia Drugs Market Dynamics
2.3.1 Fibromyalgia Drugs Industry Trends
2.3.2 Fibromyalgia Drugs Market Drivers
2.3.3 Fibromyalgia Drugs Market Challenges
2.3.4 Fibromyalgia Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fibromyalgia Drugs Players by Revenue
3.1.1 Global Top Fibromyalgia Drugs Players by Revenue (2018-2023)
3.1.2 Global Fibromyalgia Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Fibromyalgia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fibromyalgia Drugs Revenue
3.4 Global Fibromyalgia Drugs Market Concentration Ratio
3.4.1 Global Fibromyalgia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fibromyalgia Drugs Revenue in 2022
3.5 Fibromyalgia Drugs Key Players Head office and Area Served
3.6 Key Players Fibromyalgia Drugs Product Solution and Service
3.7 Date of Enter into Fibromyalgia Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fibromyalgia Drugs Breakdown Data by Type
4.1 Global Fibromyalgia Drugs Historic Market Size by Type (2018-2023)
4.2 Global Fibromyalgia Drugs Forecasted Market Size by Type (2024-2033)
5 Fibromyalgia Drugs Breakdown Data by Application
5.1 Global Fibromyalgia Drugs Historic Market Size by Application (2018-2023)
5.2 Global Fibromyalgia Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Fibromyalgia Drugs Market Size (2018-2033)
6.2 North America Fibromyalgia Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Fibromyalgia Drugs Market Size by Country (2018-2023)
6.4 North America Fibromyalgia Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Fibromyalgia Drugs Market Size (2018-2033)
7.2 Europe Fibromyalgia Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Fibromyalgia Drugs Market Size by Country (2018-2023)
7.4 Europe Fibromyalgia Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fibromyalgia Drugs Market Size (2018-2033)
8.2 Asia-Pacific Fibromyalgia Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Fibromyalgia Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Fibromyalgia Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Fibromyalgia Drugs Market Size (2018-2033)
9.2 Latin America Fibromyalgia Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Fibromyalgia Drugs Market Size by Country (2018-2023)
9.4 Latin America Fibromyalgia Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fibromyalgia Drugs Market Size (2018-2033)
10.2 Middle East & Africa Fibromyalgia Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Fibromyalgia Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Fibromyalgia Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Fibromyalgia Drugs Introduction
11.1.4 Pfizer Revenue in Fibromyalgia Drugs Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Fibromyalgia Drugs Introduction
11.2.4 Eli Lilly Revenue in Fibromyalgia Drugs Business (2018-2023)
11.2.5 Eli Lilly Recent Development
11.3 Actavis
11.3.1 Actavis Company Detail
11.3.2 Actavis Business Overview
11.3.3 Actavis Fibromyalgia Drugs Introduction
11.3.4 Actavis Revenue in Fibromyalgia Drugs Business (2018-2023)
11.3.5 Actavis Recent Development
11.4 Merck Sharp and Dohme
11.4.1 Merck Sharp and Dohme Company Detail
11.4.2 Merck Sharp and Dohme Business Overview
11.4.3 Merck Sharp and Dohme Fibromyalgia Drugs Introduction
11.4.4 Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2018-2023)
11.4.5 Merck Sharp and Dohme Recent Development
11.5 Daiichi Sankyo
11.5.1 Daiichi Sankyo Company Detail
11.5.2 Daiichi Sankyo Business Overview
11.5.3 Daiichi Sankyo Fibromyalgia Drugs Introduction
11.5.4 Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2018-2023)
11.5.5 Daiichi Sankyo Recent Development
11.6 Innovative Med Concepts
11.6.1 Innovative Med Concepts Company Detail
11.6.2 Innovative Med Concepts Business Overview
11.6.3 Innovative Med Concepts Fibromyalgia Drugs Introduction
11.6.4 Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2018-2023)
11.6.5 Innovative Med Concepts Recent Development
11.7 Meda
11.7.1 Meda Company Detail
11.7.2 Meda Business Overview
11.7.3 Meda Fibromyalgia Drugs Introduction
11.7.4 Meda Revenue in Fibromyalgia Drugs Business (2018-2023)
11.7.5 Meda Recent Development
11.8 Meiji Seika
11.8.1 Meiji Seika Company Detail
11.8.2 Meiji Seika Business Overview
11.8.3 Meiji Seika Fibromyalgia Drugs Introduction
11.8.4 Meiji Seika Revenue in Fibromyalgia Drugs Business (2018-2023)
11.8.5 Meiji Seika Recent Development
11.9 Switch Biotech
11.9.1 Switch Biotech Company Detail
11.9.2 Switch Biotech Business Overview
11.9.3 Switch Biotech Fibromyalgia Drugs Introduction
11.9.4 Switch Biotech Revenue in Fibromyalgia Drugs Business (2018-2023)
11.9.5 Switch Biotech Recent Development
11.10 Theravance
11.10.1 Theravance Company Detail
11.10.2 Theravance Business Overview
11.10.3 Theravance Fibromyalgia Drugs Introduction
11.10.4 Theravance Revenue in Fibromyalgia Drugs Business (2018-2023)
11.10.5 Theravance Recent Development
11.11 Zynerba Pharmaceuticals
11.11.1 Zynerba Pharmaceuticals Company Detail
11.11.2 Zynerba Pharmaceuticals Business Overview
11.11.3 Zynerba Pharmaceuticals Fibromyalgia Drugs Introduction
11.11.4 Zynerba Pharmaceuticals Revenue in Fibromyalgia Drugs Business (2018-2023)
11.11.5 Zynerba Pharmaceuticals Recent Development
11.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
11.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Company Detail
11.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
11.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Introduction
11.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Drugs Business (2018-2023)
11.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Fibromyalgia Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Serotonin Norepinephrine Reuptake Inhibitors
Table 3. Key Players of GABA Analogs
Table 4. Key Players of Other
Table 5. Global Fibromyalgia Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Fibromyalgia Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Fibromyalgia Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Fibromyalgia Drugs Market Share by Region (2018-2023)
Table 9. Global Fibromyalgia Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Fibromyalgia Drugs Market Share by Region (2024-2033)
Table 11. Fibromyalgia Drugs Market Trends
Table 12. Fibromyalgia Drugs Market Drivers
Table 13. Fibromyalgia Drugs Market Challenges
Table 14. Fibromyalgia Drugs Market Restraints
Table 15. Global Fibromyalgia Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Fibromyalgia Drugs Market Share by Players (2018-2023)
Table 17. Global Top Fibromyalgia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Drugs as of 2022)
Table 18. Ranking of Global Top Fibromyalgia Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Fibromyalgia Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Fibromyalgia Drugs Product Solution and Service
Table 22. Date of Enter into Fibromyalgia Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Fibromyalgia Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Fibromyalgia Drugs Revenue Market Share by Type (2018-2023)
Table 26. Global Fibromyalgia Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Fibromyalgia Drugs Revenue Market Share by Type (2024-2033)
Table 28. Global Fibromyalgia Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Fibromyalgia Drugs Revenue Market Share by Application (2018-2023)
Table 30. Global Fibromyalgia Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Fibromyalgia Drugs Revenue Market Share by Application (2024-2033)
Table 32. North America Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Fibromyalgia Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Fibromyalgia Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Fibromyalgia Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Fibromyalgia Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Fibromyalgia Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Fibromyalgia Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Fibromyalgia Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Fibromyalgia Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Fibromyalgia Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Fibromyalgia Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Fibromyalgia Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Fibromyalgia Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Fibromyalgia Drugs Product
Table 50. Pfizer Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Eli Lilly Company Detail
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Fibromyalgia Drugs Product
Table 55. Eli Lilly Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 56. Eli Lilly Recent Development
Table 57. Actavis Company Detail
Table 58. Actavis Business Overview
Table 59. Actavis Fibromyalgia Drugs Product
Table 60. Actavis Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 61. Actavis Recent Development
Table 62. Merck Sharp and Dohme Company Detail
Table 63. Merck Sharp and Dohme Business Overview
Table 64. Merck Sharp and Dohme Fibromyalgia Drugs Product
Table 65. Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 66. Merck Sharp and Dohme Recent Development
Table 67. Daiichi Sankyo Company Detail
Table 68. Daiichi Sankyo Business Overview
Table 69. Daiichi Sankyo Fibromyalgia Drugs Product
Table 70. Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 71. Daiichi Sankyo Recent Development
Table 72. Innovative Med Concepts Company Detail
Table 73. Innovative Med Concepts Business Overview
Table 74. Innovative Med Concepts Fibromyalgia Drugs Product
Table 75. Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 76. Innovative Med Concepts Recent Development
Table 77. Meda Company Detail
Table 78. Meda Business Overview
Table 79. Meda Fibromyalgia Drugs Product
Table 80. Meda Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 81. Meda Recent Development
Table 82. Meiji Seika Company Detail
Table 83. Meiji Seika Business Overview
Table 84. Meiji Seika Fibromyalgia Drugs Product
Table 85. Meiji Seika Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 86. Meiji Seika Recent Development
Table 87. Switch Biotech Company Detail
Table 88. Switch Biotech Business Overview
Table 89. Switch Biotech Fibromyalgia Drugs Product
Table 90. Switch Biotech Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 91. Switch Biotech Recent Development
Table 92. Theravance Company Detail
Table 93. Theravance Business Overview
Table 94. Theravance Fibromyalgia Drugs Product
Table 95. Theravance Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 96. Theravance Recent Development
Table 97. Zynerba Pharmaceuticals Company Detail
Table 98. Zynerba Pharmaceuticals Business Overview
Table 99. Zynerba Pharmaceuticals Fibromyalgia Drugs Product
Table 100. Zynerba Pharmaceuticals Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 101. Zynerba Pharmaceuticals Recent Development
Table 102. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Detail
Table 103. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
Table 104. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Product
Table 105. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Drugs Business (2018-2023) & (US$ Million)
Table 106. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fibromyalgia Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Fibromyalgia Drugs Market Share by Type: 2022 VS 2033
Figure 3. Serotonin Norepinephrine Reuptake Inhibitors Features
Figure 4. GABA Analogs Features
Figure 5. Other Features
Figure 6. Global Fibromyalgia Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Fibromyalgia Drugs Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Fibromyalgia Drugs Report Years Considered
Figure 12. Global Fibromyalgia Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Fibromyalgia Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Fibromyalgia Drugs Market Share by Region: 2022 VS 2033
Figure 15. Global Fibromyalgia Drugs Market Share by Players in 2022
Figure 16. Global Top Fibromyalgia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Drugs as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Fibromyalgia Drugs Revenue in 2022
Figure 18. North America Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Fibromyalgia Drugs Market Share by Country (2018-2033)
Figure 20. United States Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Fibromyalgia Drugs Market Share by Country (2018-2033)
Figure 24. Germany Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Fibromyalgia Drugs Market Share by Region (2018-2033)
Figure 32. China Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Fibromyalgia Drugs Market Share by Country (2018-2033)
Figure 40. Mexico Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Fibromyalgia Drugs Market Share by Country (2018-2033)
Figure 44. Turkey Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Fibromyalgia Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 47. Eli Lilly Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 48. Actavis Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 49. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 50. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 51. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 52. Meda Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 53. Meiji Seika Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 54. Switch Biotech Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 55. Theravance Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 56. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 57. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Drugs Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed